All stock lists
Aspen Neuroscience, Inc. (NASDAQ:ASPE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
12.26-0.79 (-6.02%)
Insider Score
––Not scored
ASPE Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ASPE Stock Insider Trading Activity
ASPE stock’s insider trading shows 4 purchases for an estimated $38.00M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$38.00M bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ARCH Venture Fund X, L.P. Other | Buy | 66,666 | $15.00 | $999.99K | New | 66,666 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 187,182 | — | — | 281% | 253,848 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 298,258 | — | — | 117% | 552,106 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 286,304 | — | — | 51.9% | 838,410 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 295,490 | — | — | 35.2% | 1,133,900 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 259,948 | — | — | 22.9% | 1,393,848 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Buy | 66,667 | $15.00 | $1.00M | New | 66,667 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 298,258 | — | — | 447% | 364,925 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 286,304 | — | — | 78.5% | 651,229 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 295,490 | — | — | 45.4% | 946,719 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Converted | 214,355 | — | — | 22.6% | 1,161,074 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Fund X, L.P. Other | Buy | 1,200,000 | $15.00 | $18.00M | New | 1,200,000 | Nov 2, 2026 | — | Form 4 |
| ARCH Venture Partners XIV, L.P. Other | Buy | 1,200,000 | $15.00 | $18.00M | New | 1,200,000 | Nov 2, 2026 | — | Form 4 |
| Spaventa Andrew Director | Converted | 70,194 | — | — | New | 70,194 | Nov 2, 2026 | — | Form 4 |
| Spaventa Andrew Director | Converted | 180,221 | — | — | New | 180,221 | Nov 2, 2026 | — | Form 4 |
| Hasnain Faheem Director | Converted | 14,913 | — | — | New | 14,913 | Nov 2, 2026 | — | Form 4 |
| Hasnain Faheem Director | Converted | 14,316 | — | — | New | 14,316 | Nov 2, 2026 | — | Form 4 |
| Hasnain Faheem Director | Converted | 7,120 | — | — | New | 7,120 | Nov 2, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.